Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:XLRN

Acceleron Pharma (XLRN) Stock Price, News & Analysis

Acceleron Pharma logo

About Acceleron Pharma Stock (NASDAQ:XLRN)

Advanced Chart

Key Stats

Today's Range
$178.75
$178.75
50-Day Range
$172.08
$179.68
52-Week Range
$108.82
$189.99
Volume
N/A
Average Volume
572,759 shs
Market Capitalization
$10.93 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive XLRN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acceleron Pharma and its competitors with MarketBeat's FREE daily newsletter.

XLRN Stock News Headlines

Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
Acceleron Banks on Muons for Colder Fusion
ORBIMED CAPITAL GP II LLC's Net Worth
XLRN Historical Data
See More Headlines

XLRN Stock Analysis - Frequently Asked Questions

Acceleron Pharma Inc. (NASDAQ:XLRN) issued its earnings results on Thursday, November, 4th. The biopharmaceutical company reported ($1.16) EPS for the quarter, missing analysts' consensus estimates of ($0.98) by $0.18. Acceleron Pharma's quarterly revenue was up 51.6% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that Acceleron Pharma investors own include Bristol Myers Squibb (BMY), Gilead Sciences (GILD), Advanced Micro Devices (AMD), Meta Platforms (META), Pfizer (PFE), NVIDIA (NVDA) and Vertex Pharmaceuticals (VRTX).

Company Calendar

Last Earnings
11/04/2021
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:XLRN
CIK
1280600
Employees
312
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($4.21)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$166.03 million
Net Margins
-226.01%
Pretax Margin
-225.99%
Return on Equity
-32.11%
Return on Assets
-29.45%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
12.14
Quick Ratio
12.14

Sales & Book Value

Annual Sales
$92.52 million
Price / Sales
118.15
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$11.74 per share
Price / Book
15.23

Miscellaneous

Outstanding Shares
61,156,000
Free Float
60,116,000
Market Cap
$10.93 billion
Optionable
Optionable
Beta
0.13

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:XLRN) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners